Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde?

Cytokine and Growth Factor Reviews

Volumn 20, Issue 1, 2009, Pages 77-85

  Rampino, Teresa ^a   Gregorini, Marilena ^a   Dal Canton, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Acute renal failure; Glomerulonephritis; Hepatocyte Growth Factor; Scatter Factors

Indexed keywords

CISPLATIN; HEPARIN; MACROPHAGE ACTIVATING FACTOR; MERCURIC CHLORIDE; SCATTER FACTOR RECEPTOR;

ACUTE KIDNEY FAILURE; APOPTOSIS; CELL INFILTRATION; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; NONHUMAN; ONCOGENE; ORGANOGENESIS; PARTIAL NEPHRECTOMY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; TUMOR GROWTH;

ANIMALS; GLOMERULONEPHRITIS; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; RENAL DIALYSIS;

EID: 60949088097     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.01.004     Document Type: Review

References (99)

1. Stoker M., Gherardi E., Perryman M., and Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327 (1987) 239-242
2. Nakamura T., Nawa K., Ichihara A., Kaise N., and Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224 2 (1987) 311-316
3. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88 16 (1991) 7001-7005
4. Tashiro K., Hagiya M., Nishizawa T., Seki T., Shimonishi M., Shimizu S., et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci USA 87 8 (1990) 3200-3204
5. Han S., Stuart L.A., and Degen S.J. Characterization of DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30 40 (1991) 9768-9780
6. Shimamoto A., Kimura T., Matsumoto K., and Nakamura T. Hepatocyte growth factor-like protein is identical to macrophage stimulating protein. FEBS Lett 333 1-2 (1993) 61-66
7. Leonard E.J., and Skeel A. A serum protein that stimulates macrophage movement, chemotaxis and spreading. Exp Cell Res 102 2 (1976) 434-438
8. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11 13 (1992) 4825-4833
9. Wang M.H., Gonias S.L., Skeel A., Wolf B.B., Yoshimura T., and Leonard E.J. Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family. J Biol Chem 269 19 (1994) 13806-13810
10. Wang M.H., Yoshimura T., Skeel A., and Leonard E.J. Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem 269 5 (1994) 3436-3440
11. Noji S., Tashiro K., Kojama E., Nohno T., Ohyama K., Taniguchi S., et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 173 1 (1990) 42-47
12. Libetta C., Rampino T., Esposito C., Fornoni A., Semeraro L., and Dal Canton A. Stimulation of hepatocyte growth factor in human acute renal failure. Nephron 80 1 (1998) 41-45
13. Takai K., Hara J., Matsumoto K., Hosoi G., Osugi Y., Tawa A., et al. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood 89 (1997) 1560-1565
14. Rampino T., Libetta C., De Simone W., Ranghino A., Soccio G., Gregorini M., et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 53 5 (1998) 1382-1388
15. Rampino T., Gregorini M., Camussi G., Conaldi P.G., Soccio G., Maggio M., et al. Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis. Nephrol Dial Transplant 20 6 (2005) 1066-1074
16. Morimoto A., Okamura K., Hamanaka R., Sato Y., Shima N., Higashio K., et al. Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. Biochem Biophys Res Commun 179 2 (1991) 1042-1049
17. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., and Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 43 5 (1996) 554-564
18. Grano M., Galini F., Zambonin G., Colucci S., Cottone E., Zallone A.Z., et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 93 15 (1996) 7644-7648
19. Kolatsi-Joannou M., Woolf A.S., Hardman P., White S.J., Gordge M., and Henderson R.M. The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. J Cell Sci 108 12 (1995) 3703-3714
20. Rampino T., Libetta C., Guallini P., Gregorini M., Soccio G., Maggio M., et al. Cytokines are "injurins" and caused hepatocyte growth factor release during dialysis. Haematologica 83 Meeting suppl. (1998) 10-11
21. Maffè A., and Comoglio P.M. HGF controls branched morphogenesis in tubular glands. Eur J Morphol 36 Suppl. (1998) 74-81
22. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119 (1992) 629-641
23. Gutierrez H., Dolcet X., Tolcos M., and Davies A. HGF regulates the development of cortical pyramidal dendrites. Development 131 15 (2004) 3717-3726
24. Longati P., Albero D., and Comoglio P.M. Hepatocyte growth factor is a pleiotropic factor protecting epithelial cells from apoptosis. Cell Death Differ 3 1 (1996) 23-28
25. Esposito C., Parrilla B., De Mauri A., Cornacchia F., Fasoli G., Foschi A., et al. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int 67 6 (2005) 2143-2150
26. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanism of action. Am J Physiol Renal Physiol 287 1 (2004) F7-F16
27. Sakurai H., and Nigam S.K. Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am J Physiol 272 2 (1997) F139-F146
28. Gong R., Rifai A., Tolbert E.M., Centracchio J.M., and Dworkin L.D. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 14 12 (2003) 3047-3060
29. Rosário M., and Birchmeier W. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol 13 6 (2003) 328-335
30. Rampino T., Gregorini M., Guidetti C., Broggini M., Marchini S., Bonomi R., et al. KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/Scatter Factor in renal tubular cells. Growth Factor 25 6 (2007) 382-391
31. Matsumoto K., and Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239 (1997) 639-644
32. Zhang Y.W., and Cande Woude G.G. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 88 (2003) 408-417
33. Skeel A., and Leonard E.J. Action and target cell specificity of human macrophage-stimulating protein (MSP). J Immunol 152 9 (1994) 4618-4623
34. Liu Q.P., Fruit K., Ward J., and Correll P.H. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J Immunol 163 12 (1999) 6606-6613
35. Rampino T., Soccio G., Gregorini M., Guidetti C., Marasà M., Maggio M., et al. Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis. J Am Soc Nephrol 18 5 (2007) 1486-1496
36. Wang M.H., Dlugosz A.A., Sun Y., Suda T., Skeel A., and Leonard E.J. Macrophage-stimulating protein induces proliferation and migration of murin keratinocytes. Exp Cell Res 10 (1996) 39-46
37. Medico E., Mongiovi A.M., Huff J., Jelinek M.A., Follensi A., Gaudino G., et al. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7 4 (1996) 495-504
38. Rampino T., Collesi C., Gregorini M., Maggio M., Soccio G., Guallini P., et al. Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. J Am Soc Nephrol 13 3 (2002) 649-657
39. Sakamoto O., Iwama A., Amitani R., Takehara T., Yamaguchi N., Yamamoto T., et al. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J Clin Invest 99 4 (1997) 701-709
40. Banu N., Price D.J., London R., Deng B., Mark M., Godowski P.J., et al. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J Immunol 156 8 (1996) 2933-2940
41. Gaudino G., Avantaggiato V., Follenzi A., Acampora D., Simeone A., and Comoglio P.M. The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11 12 (1995) 2627-2637
42. Broxmeyer H.E., Cooper S., Li Z.H., Lu L., Sarris A., Wang M.H., et al. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann Hematol 73 (1996) 1-9
43. Forgie A., Wyatt S., Correl P.H., and Davies A.M. Macrophage stimulating protein is a target-derived neurotrophic factor for developing sensory and sympathetic neurons. Development 130 (2003) 995-1002
44. Danilkovitch A., Donley S., Skeel A., and Leonard E.J. Two independent signalling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol 20 (2000) 2218-2227
45. Chen Y.Q., Zhou Y.Q., and Wang M.H. Activation of the RON receptor tyrosine kinase protects murine macrophages from apoptotic death induced by bacterial lipopolysaccharide. J Leukoc Biol 71 (2002) 359-366
46. Wang D., Shen Q., Chen Y.Q., and Wang M.H. Collaborative activities of macrophage-stimulating protein and transforming growth factor-(1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Oncogene 23 (2004) 1668-1680
47. Bezerra J.A., Witte D.P., Aronow B.J., and Degen S.J. Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 18 2 (1993) 394-399
48. Rampino T., Gregorini M., Soccio G., Maggio M., Rosso R., Malvezzi P., et al. The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. Am J Surg Pathol 27 6 (2003) 779-785
49. Ohshiro K., Iwama A., Matsuno K., Ezaki T., Sakamoto O., Hamaguchi I., et al. Molecular cloning of rat macrophage-stimulating protein and its involvement in the male reproductive system. Biochem Biophys Res Commun 227 1 (1996) 273-280
50. Danilkovitch A., and Leonard E.J. Kinases involved in MSP/RON signaling. J Leukoc Biol 65 (1999) 345-348
51. Wang M.H., Montero-Julian F.A., Dauny I., and Leonard E.J. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 13 10 (1996) 2167-2175
52. Danilkovitch A., Skeel A., and Leonard E.J. Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanism. Exp Cell Res 248 (1999) 575-582
53. Santoro M.M., Gaudino G., and Marchisio P.C. The MSP receptor regulates α6(4 and α3(1 integrins via 14-3-3 proteins in keratinocyte migration. Dev Cell 5 (2003) 257-271
54. Wang M.H., Skeel A., and Leonard E.J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 97 3 (1996) 720-727
55. Kurihara N., Iwama A., Tatsumi J., Ikeda K., and Suda T. Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells. Blood 87 9 (1996) 3704-3710
56. Stella M.C., Vercelli A., Repici M., Follenzi A., and Comoglio P.M. Macrophage stimulating protein is a novel neurotrophic factor. Mol Biol Cell 12 (2001) 1341-1352
57. Teal H.E., Craici A., Paulson R.F., and Correll P.H. Macrophage-stimulating protein cooperates with erythropoietin to induce colony formation and MAP kinase activation in primary erythroid progenitor cells. J Hematother Stem Cell Res 12 (2003) 165-177
58. Bezerra J.A., Carrick T.L., Degen J.L., Witte D., and Degen S.J.F. Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. J Clin Invest 101 5 (1998) 1175-1183
59. Igawa T., Matsumoto K., Kanda S., Saito Y., and Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265 2 (1993) F61-F69
60. Yanagita K., Nagaike M., Ishibashi H., Niho Y., Matsumoto K., and Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 182 2 (1992) 802-809
61. Kawaida K., Matsumoto K., Shimazu H., and Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91 10 (1994) 4357-4361
62. Vargas G.A., Hoeflich A., and Jehle P.M. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 57 4 (2000) 1426-1436
63. Dai C., Yang J., and Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 13 2 (2002) 411-422
64. Fiaschi-Taesch N.M., Santos S., Reddy V., Van Why S.H., Philbrick W.F., Ortega A., et al. Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 15 1 (2004) 112-125
65. Nagano T., Mori-Kudo I., Kawamura T., Taiji M., and Noguchi H. Pre-or post-treatment with hepatocyte growth factor prevents glycerol-induced acute renal failure. Ren Fail 26 1 (2004) 5-11
66. Tracz M.J., Alam J., and Nath K.A. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18 2 (2007) 414-420
67. Mizuno S., and Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 166 6 (2005) 1895-1905
68. Matsumoto K., and Nakamura T. Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun 227 2 (1996) 455-461
69. Rampino T., Arbustini E., Gregorini M., Guallini P., Libetta C., Maggio M., et al. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 56 6 (1999) 2286-2291
70. Mori T., Shimizu A., Masuda Y., Fukuda Y., and Yamanaka N. Hepatocyte growth factor-stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis. Nephron Exp Nephrol 94 2 (2003) e44-54
71. Liu Y., Tolbert E.M., Sun A.M., and Dworkin L.D. Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol 271 2 (1996) F679-F688
72. Le Hir M., Keller C., Eschmann V., Hähnel B., Hosser H., and Kriz W. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 12 10 (2001) 2060-2071
73. Mizuno S., Kurosawa T., Matsumoto K., Horikawa Y.M., Okamoto M., and Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101 9 (1998) 1827-1834
74. Kagawa T., Takemura G., Kosai K., Murata I., Ohno T., Takahashi T., et al. Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice. Nephron Physiol 102 3-4 (2006) 92-102
75. Dai C., Yang J., Bastacky S., Xia J., Li Y., and Liu Y. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 15 10 (2004) 2637-2647
76. Liu Y., Rajur K., Tolbert E., and Dworkin L.D. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58 5 (2000) 2028-2043
77. Mizui M., Isaka Y., Takabatake Y., Mizuno S., Nakamura T., Ito T., et al. Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 65 6 (2004) 2041-2053
78. Okada H., Watanabe Y., Inoue T., Kobayashi T., Kanno Y., Shiota G., et al. Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant 18 (2003) 2515-2523
79. Liu Y., and Yang J. Hepatocyte growth factor: new arsenal in the fights against renal fibrosis?. Kidney Int 70 2 (2006) 238-240
80. Herrero-Fresneda I., Torras J., Franquesa M., Vidal A., Cruzado J.M., Lloberas N., et al. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 70 2 (2006) 265-274
81. Okunishi K., Dohi M., Nakagome K., Tanaka R., Mizuno S., Matsumoto K., et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175 7 (2005) 4745-4753
82. Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94 2 (1997) 701-706
83. Laping N.J., Olson B.A., Ho T., Ziyadeh F.N., and Albrightson C.R. Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells. Biochem Pharmacol 59 (2000) 847-853
84. Wang S.N., LaPage J., and Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57 3 (2000) 1002-1014
85. Malatino L.S., Mallamaci F., Benedetto F.A., Bellanuova I., Cataliotti A., Tripepi G., et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 36 (2000) 945-952
86. Rampino T., Cancarini G., Gregorini M., Guallini P., Maggio M., Soccio G., et al. Hepatocyte growth factor released during peritonitis is active on mesothelial cells. Am J Pathol 159 4 (2001) 1275-1285
87. Masunaga Y., Muto S., Asakura S., Akimoto T., Homma S., Kusano E., et al. Ascites from patients with encapsulating peritoneal sclerosis augments NIH/3T3 fibroblast proliferation. Ther Apher Dial 7 5 (2003) 486-493
88. Nakamura S., and Niwa T. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol 16 1 (2005) 144-150
89. Yoshimura R., Watanable Y., Kasai S., Wada S., Ohyama A., Hase T., et al. Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Transplant Int 15 4 (2002) 156-162
90. Azuma H., Takahara S., Matsumoto K., Ichimaru N., Wang J.D., Moriyama T., et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12 6 (2001) 1280-1292
91. Takada S., Namiki M., Takahara S., Matsumiya K., Kondoh N., Kokado Y., et al. Serum HGF levels in acute renal rejection after living related renal transplantation. Transplant Int 9 2 (1996) 151-154
92. Pisters L.L., El-Naggar A.K., Luo W., Malpica A., and Lin S.H. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol 158 3 Pt 1 (1997) 724-728
93. Miyata Y., Kanetake H., and Kanda S. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma. Clin Cancer Res 12 (2006) 4876-4881
94. Morris M.R., Gentle D., Abdulrahman M., Maina E.N., Gupta K., Banks R.E., et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 65 11 (2005) 4598-4606
95. Yamauchi M., Kataoka H., Itoh H., Seguchi T., Hasui Y., and Osada Y. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. J Urol 17 2 Pt 1 (2004) 890-896
96. Peace B.E., Hughes M.J., Degen S.J., and Waltz S.E. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20 43 (2001) 6142-6151
97. Konda R., Sato H., Hatafuku F., Nozawa T., Ioritani N., and Fujioka T. Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma. J Urol 171 6 Pt 1 (2004) 2166-2170
98. Horie S., Higashihara E., Nutahara K., Mikami Y., Okubo A., Kano M., et al. Mediation of renal cyst formation by hepatocyte growth factor. Lancet 344 8925 (1994) 789-791
99. Carone F.A., Nakamura S., Bacallao R., Nelson W.J., Khokha M., and Kanwar Y.S. Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys. Kidney Int 45 3 (1995) 861-868